Ignite Creation Date:
2025-12-25 @ 1:41 AM
Ignite Modification Date:
2026-06-30 @ 9:54 AM
Study NCT ID:
NCT01257594
Status:
COMPLETED
Last Update Posted:
2023-05-25
First Post:
2010-12-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
EGFR Inhibition Using Weekly Erlotinib for Recurrent Malignant Gliomas
Sponsor:
Andrew B Lassman, MD
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
AAAJ7500
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None